How much does a box of Panobinostat cost?

Panobinostat (Panobinostat) is a histone deacetylase inhibitor that has been widely studied and used in the field of cancer treatment. This drug mainly blocks the growth and spread of cancer cells by affecting the structure of cell chromatin and regulating gene expression levels.

Panobinostat is not currently on the market in China, so patients cannot purchase it domestically and need to purchase panobinostat through overseas channels. There are only panobinostat original drugs available abroad, mainly the European version of the Swiss Novartis original drug, which is expensive, as high as more than 40,000 yuan.

The mechanism of action is based on the inhibition of histone deacetylase. Histones are proteins that interact with DNA and are involved in regulating gene expression. Inhibition of histone deacetylase results in reduced acetylation levels on histones, thereby changing chromatin structure and affecting gene transcription and expression. In cancer types such as multiple myeloma, panobinostat's inhibitory effects help control abnormal proliferation of cancer cells, preventing them from growing and spreading.

Pabinostat has been approved to treat multiple myeloma, particularly in patients whose disease has progressed despite multiple lines of therapy. It is often used in combination with other anticancer drugs to enhance the effectiveness of treatment.

However, the use of panobinostat is associated with some adverse effects, including hematologic toxicity, cardiotoxicity, and gastrointestinal effects. Therefore, when applying this drug, doctors need to carefully assess the patient's physical condition and conduct close monitoring to ensure optimal therapeutic effects while minimizing adverse effects.

Overall, as a new anti-cancer drug, panobinostat has shown potential efficacy in cancer treatment, providing patients with a new treatment option and bringing new hope to the field of cancer research and treatment.